Advertisement

Loading...

CordovaCann Corp.

CDVA.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
$0.00(0.00%)
Canadian Market opens in 16h 35m

CordovaCann Corp. Fundamental Analysis

CordovaCann Corp. (CDVA.CN) shows moderate financial fundamentals with a PE ratio of -1.02, profit margin of -19.16%, and ROE of 50.26%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 3.28%.

Key Strengths

ROE50.26%
Cash Position21.35%
PEG Ratio-0.15

Areas of Concern

Operating Margin3.29%
Current Ratio0.18
We analyze CDVA.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 38.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
38.5/100

We analyze CDVA.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

CDVA.CN struggles to generate sufficient returns from assets.

ROA > 10%
-41.56%

Valuation Score

Excellent

CDVA.CN trades at attractive valuation levels.

PE < 25
-1.02
PEG Ratio < 2
-0.15

Growth Score

Weak

CDVA.CN faces weak or negative growth trends.

Revenue Growth > 5%
3.28%
EPS Growth > 10%
-80.15%

Financial Health Score

Moderate

CDVA.CN shows balanced financial health with some risks.

Debt/Equity < 1
-0.87
Current Ratio > 1
0.18

Profitability Score

Moderate

CDVA.CN maintains healthy but balanced margins.

ROE > 15%
50.26%
Net Margin ≥ 15%
-19.16%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CDVA.CN Expensive or Cheap?

P/E Ratio

CDVA.CN trades at -1.02 times earnings. This suggests potential undervaluation.

-1.02

PEG Ratio

When adjusting for growth, CDVA.CN's PEG of -0.15 indicates potential undervaluation.

-0.15

Price to Book

The market values CordovaCann Corp. at -0.46 times its book value. This may indicate undervaluation.

-0.46

EV/EBITDA

Enterprise value stands at 1.65 times EBITDA. This is generally considered low.

1.65

How Well Does CDVA.CN Make Money?

Net Profit Margin

For every $100 in sales, CordovaCann Corp. keeps $-19.16 as profit after all expenses.

-19.16%

Operating Margin

Core operations generate 3.29 in profit for every $100 in revenue, before interest and taxes.

3.29%

ROE

Management delivers $50.26 in profit for every $100 of shareholder equity.

50.26%

ROA

CordovaCann Corp. generates $-41.56 in profit for every $100 in assets, demonstrating efficient asset deployment.

-41.56%

Following the Money - Real Cash Generation

Operating Cash Flow

CordovaCann Corp. generates limited operating cash flow of $873.17K, signaling weaker underlying cash strength.

$873.17K

Free Cash Flow

CordovaCann Corp. produces free cash flow of $856.49K, offering steady but limited capital for shareholder returns and expansion.

$856.49K

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

CDVA.CN converts 31.20% of its market value into free cash.

31.20%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.02

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.15

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.46

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.20

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.87

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.18

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.50

vs 25 benchmark

ROA

Return on assets percentage

-0.42

vs 25 benchmark

ROCE

Return on capital employed

-0.16

vs 25 benchmark

How CDVA.CN Stacks Against Its Sector Peers

MetricCDVA.CN ValueSector AveragePerformance
P/E Ratio-1.0227.91 Better (Cheaper)
ROE50.26%687.00% Weak
Net Margin-19.16%-45285.00% (disorted) Weak
Debt/Equity-0.870.33 Strong (Low Leverage)
Current Ratio0.182795.76 Weak Liquidity
ROA-41.56%-13557.00% (disorted) Weak

CDVA.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CordovaCann Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

3435.20%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

75.74%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

145.45%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ